Another group has reported that disruption of DNA repair and epigenetic state by knockdown of a BER enzyme thymine DNA glycosylase (TDG) may be a potent strategy against melanoma, and furthermore, the group also evaluated candidate inhibitors of TDG for the treatment of melanoma [143]. The gene discussed is TDG; the disease is melanoma.